| Revenue growth | 9.4% YoY growth; consolidate revenue at ₹295.5 Cr. |
|---|---|
| Margins | EBITDA margins expanded significantly to 12.7% YoY. |
| Demand visibility | Strong demand in domestic orthopedics and oncology segments. |
| Management confidence | High confidence in India business; cautiously optimistic on international recovery. |
Growth
Revenue grew 9.4% YoY; EBITDA margins expanded to 12.7% from 9.7% via cost optimization and improved segment mix.
Outlook
Management guides for sustained 15% CAGR growth and intends to scale the implant business to ₹600-650cr by 2030.
Risks
International revenue dipped due to Middle East conflicts; rising debt from acquisitions remains a concern for leverage ratios.
Earnings Call filed with NSE, NSE: SHALBY. Summary written with AI assistance from the document.
Shalby Ltd: key numbers
- Share price
- ₹134.62
- Market cap
- ₹1,454 Cr
- Revenue (annual)
- ₹1,141 Cr
- Net profit (annual)
- ₹37.39 Cr
- P/E (TTM)
- 37.0×Sector 53.1×
- Promoter holding
- 74.33%+0.00% QoQ
- FII holding
- 4.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shalby Ltd
All →Shalby Management Change
Shareholders at the AGM did not approve the appointment of Mr. Shanay Vikram Shah as Director, resulting in his cessation from the Board effective September 10, 2026.
Shalby Annual General Meeting
Shalby Limited held its 22nd Annual General Meeting on September 10, 2026. The meeting covered adoption of financial statements and appointment of a whole-time director.
Shalby Other Announcement
Shalby Limited has issued a letter to shareholders providing the web-link for the Annual Report for FY 2025-26. The 22nd Annual General Meeting is scheduled for September 10, 2026.
Shalby Business Update
Shalby Limited filed its Business Responsibility & Sustainability Report (BRSR) for FY 2025-26 as mandated by SEBI LODR regulations.
Shalby Annual General Meeting
Shalby Ltd announced its 22nd Annual General Meeting scheduled for September 10, 2026, and filed its Annual Report for FY 2025-26.
Shalby Earnings Call Transcript: Key Takeaways
Shalby reported a modest 11.6% revenue growth with its MetLife business reaching EBITDA break-even, but hospital margins remain under pressure due to new doctor recruitments.
- Call
- Guides 20% growth